Oct 13, 2026 08:31AM
Oct 13, 2026 08:31AM
Aug 6, 2026 04:05PM
May 14, 2026 04:05PM
Mar 26, 2026 08:31AM
Jan 5, 2026 08:32AM
Jan 5, 2026 08:30AM MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects
Nov 6, 2025 08:31AM
Sep 4, 2025 06:14AM
Aug 7, 2025 08:31AM
May 14, 2025 04:05PM
May 7, 2025 02:00AM
Apr 15, 2025 07:01AM
Apr 15, 2025 07:01AM MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safet
Mar 20, 2025 07:31AM
Dec 18, 2024 08:01AM
Dec 18, 2024 08:01AM

335,386 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All